Bronchoscopy: Direct Visualization of the Airways

Bronchoscopy is a procedural technique that allows clinicians to directly examine the interior of the airways, from the vocal cords through the bronchial tree, using a flexible or rigid instrument equipped with a light source and imaging capability. This page covers how the procedure works, the two principal instrument types, the clinical scenarios that prompt its use, and the criteria that guide procedural selection. Understanding bronchoscopy is foundational to interpreting pulmonary diagnostic and therapeutic pathways across a wide range of lung conditions.

Definition and scope

Bronchoscopy involves the insertion of a bronchoscope — a thin, tubular instrument — through the nose or mouth, past the vocal cords, and into the trachea and bronchial passages. The American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP) recognize bronchoscopy as a core diagnostic and interventional tool in pulmonary medicine, with procedural standards addressed in published guidelines and specialty training requirements.

The procedure divides into two primary instrument categories:

• Flexible bronchoscopy uses a fiber-optic or video-chip scope, typically 3.5–6 mm in outer diameter, that bends to follow the natural curvature of the airways. It can reach subsegmental bronchi and is performed under moderate sedation in an outpatient or inpatient setting.
• Rigid bronchoscopy uses a straight, hollow metal tube — typically 12–14 mm in diameter — that requires general anesthesia and is primarily performed in the operating room. Its larger channel accommodates bulkier instruments and provides superior airway control during hemorrhage or central obstruction.

Both types fall under procedural oversight frameworks that include facility credentialing, informed consent requirements under state medical practice acts, and equipment standards referenced by the Joint Commission (TJC) in its hospital accreditation standards. The regulatory context for pulmonary procedures addresses how federal and state oversight intersects with procedural care in this specialty.

How it works

The procedural sequence for flexible bronchoscopy follows a discrete set of phases:

1. Pre-procedure assessment — Coagulation status, platelet count, medication review (particularly anticoagulants and antiplatelet agents), and oxygen saturation baseline are evaluated. The ACCP recommends platelets above 50,000/µL and an INR below 1.5 for procedures involving biopsy.
2. Anesthesia and positioning — Topical anesthetic (typically 2–4% lidocaine) is applied to the nasal or oral passage, pharynx, and vocal cords. Moderate sedation using agents such as midazolam or propofol is administered intravenously.
3. Scope insertion and survey — The bronchoscopist advances the scope through the upper airway, visualizing the vocal cords, trachea, carina, and bilateral bronchial trees in sequence. The carina angle and mucosal appearance are assessed for abnormality.
4. Targeted intervention — Depending on clinical indication, the operator may collect bronchoalveolar lavage (BAL) fluid, obtain endobronchial or transbronchial biopsy specimens, perform brushings for cytology, or place instruments under fluoroscopic or endobronchial ultrasound (EBUS) guidance.
5. Recovery and monitoring — Continuous pulse oximetry and cardiac monitoring continue until sedation effects resolve, per standards outlined in the Centers for Medicare & Medicaid Services (CMS) Conditions of Participation for hospital-based procedures.

Endobronchial ultrasound (EBUS) bronchoscopy adds a real-time ultrasound transducer to the scope tip, enabling needle aspiration of mediastinal and hilar lymph nodes without surgical incision. EBUS-guided transbronchial needle aspiration (EBUS-TBNA) has a reported diagnostic sensitivity of approximately 89–93% for mediastinal lymph node staging in lung cancer, as documented in ATS clinical practice literature.

Common scenarios

Bronchoscopy is indicated across a defined set of clinical presentations. The most frequently encountered include:

• Unexplained hemoptysis — Direct mucosal inspection identifies endobronchial tumors, vascular malformations, or areas of active bleeding. Rigid bronchoscopy is preferred when bleeding exceeds 100–200 mL per 24 hours (massive hemoptysis threshold referenced in ACCP guidelines).
• Lung cancer staging — EBUS-TBNA samples mediastinal nodes at stations 2R, 2L, 4R, 4L, 7, 10, 11, and 12, providing tissue for both pathologic diagnosis and molecular marker analysis required by targeted therapy protocols.
• Suspected infectious pneumonia — BAL specimens yield bacterial, fungal, and mycobacterial culture data when sputum analysis is nondiagnostic. This is particularly relevant in immunocompromised patients, where organisms such as Pneumocystis jirovecii are identified primarily through BAL. For more on related presentations, see bronchiectasis and tuberculosis.
• Interstitial lung disease — Transbronchial biopsy or the newer cryobiopsy technique obtains alveolar tissue samples to characterize fibrotic or inflammatory patterns. Cryobiopsy yields specimens approximately 3–5 times larger than conventional forceps biopsy, improving diagnostic adequacy.
• Foreign body retrieval — Rigid bronchoscopy remains the standard of care for aspirated objects in pediatric and adult patients, given its superior suctioning capacity and instrument access.
• Airway obstruction — Endobronchial tumor debulking, stent placement, and balloon dilation are performed bronchoscopically; these therapeutic applications are detailed under bronchoscopic interventions.

Decision boundaries

The choice between flexible and rigid bronchoscopy, and between bronchoscopy and alternative diagnostic strategies, depends on structured clinical criteria rather than practitioner preference alone.

Flexible bronchoscopy is appropriate when the target lesion is peripheral, the patient cannot tolerate general anesthesia, or the procedure is primarily diagnostic. Rigid bronchoscopy is indicated when airway patency must be maintained mechanically during intervention, when instrument diameter requirements exceed flexible scope capacity, or when massive hemorrhage requires simultaneous suctioning and ventilation through a single lumen.

Bronchoscopy carries defined contraindications. Absolute contraindications include an uncooperative patient without available anesthesia support and refractory hypoxemia that cannot be corrected to a safe procedural threshold (typically SpO₂ above 90%). Relative contraindications — including coagulopathy, unstable cardiac arrhythmia, and recent myocardial infarction within 6 weeks — require individualized risk assessment per ATS/ACCP consensus statements.

Computed tomography (CT) bronchoscopy navigation systems, including electromagnetic navigation bronchoscopy (ENB), extend reach to lesions as small as 8–10 mm in the outer thirds of the lung where conventional scopes cannot advance. A CT scan of the chest typically precedes bronchoscopic planning for peripheral lesion sampling, providing three-dimensional airway mapping used by navigation platforms.

Complications occur in a minority of cases. The rate of significant bleeding following transbronchial biopsy is approximately 1–4%, and pneumothorax risk ranges from 1–6% depending on lesion location and technique, as reported in ACCP procedural complication literature. Procedural mortality for flexible bronchoscopy in unselected populations is estimated below 0.01%.

References

• American Thoracic Society (ATS) — Clinical practice guidelines and consensus statements on bronchoscopy and interventional pulmonology
• American College of Chest Physicians (ACCP) — CHEST journal guidelines on bronchoscopic technique, EBUS, and procedural safety thresholds
• Centers for Medicare & Medicaid Services (CMS) — Conditions of Participation — Hospital procedural monitoring and sedation standards
• The Joint Commission (TJC) — Accreditation standards for hospital-based procedural care and equipment oversight
• National Library of Medicine — MedlinePlus: Bronchoscopy — Public-access procedural overview and patient education reference

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)